Is there anyone knows how to calculate FPKM for specific UTR region or just specif exon?
-
Last edited by zjrouc; 07-27-2015, 05:53 PM. -
The same as you would for anything else. You take the number of fragments mapping to each region, divide that by the length of each region in kilobases, and then divide the results by a million. -
Then how do you count reads in that region? Manually?Comment
-
You have a plethora of choices: htseq-count, featurecounts, summarizeOverlaps (in R), bedtools intersect, samtools view (note the -c option), etc.Comment
-
So if i want to use htseq to count reads for this specif region. i need to generate a gtf file for this region, right? now i have problem with that. my htseq or cufflink results from using this own gtf file were empty. i am wondering if there are other easier waysComment
-
Yes, htseq-count requires a GTF file. If you can see alignments in IGV and you don't get any with the GTF file and htseq-count then you're probably doing something wrong. Try making a BED file and use bedtools intersect with that and the GTF file separately. If they both work and give approximately the same results then you know that you were using htseq-count wrong. If they give vastly different results then there's likely something wrong with the GTF file. If they don't give any alignments then you've screwed up specifying the region.Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment